Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives.

Pharmaceuticals (Basel) · 2021 · PMC8707981 · PMID 34959672

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

However, as the incidence of Ebola infection dropped, trial enrollment decreased, and the study failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.